Vector Science & Therapeutics Secures Long-Term Manufacturing with LyoGenesis Plus Option Agreement#USA#Mequon#MPP_Group#Vector_Science#LyoGenesis_Plus
Vector Science & Therapeutics Secures Long-Term Manufacturing with LyoGenesis Plus Option Agreement
Vector Science & Therapeutics has entered a significant option agreement with LyoGenesis Plus, marking a robust step into the peptide market with FDA-registered manufacturing.
third-news.com
May 14, 2026 at 12:12 AM
Vector Science & Therapeutics Secures Long-Term Manufacturing with LyoGenesis Plus Option Agreement#USA#Mequon#MPP_Group#Vector_Science#LyoGenesis_Plus
Vector Science & Therapeutics Partners with MPP Group to Innovate in Peptide Development and Manufacturing#USA#Mequon#MPP_Group#Vector_Science#Peptide_Market
Vector Science & Therapeutics Partners with MPP Group to Innovate in Peptide Development and Manufacturing
Vector Science & Therapeutics has signed a three-year deal with MPP Group LLC to develop pharmaceutical-grade peptide formulations. This agreement enhances Vector's entry into the expanding peptide market valued at $80.8 billion.
third-news.com
May 11, 2026 at 12:58 PM
Vector Science & Therapeutics Partners with MPP Group to Innovate in Peptide Development and Manufacturing#USA#Mequon#MPP_Group#Vector_Science#Peptide_Market
Milwaukee Capital Partners Completes All-Cash Acquisition of MPP Group#United_States#Milwaukee#Concordia_University#Milwaukee_Capital#MPP_Group
Milwaukee Capital Partners Completes All-Cash Acquisition of MPP Group
Milwaukee Capital Partners has successfully acquired MPP Group in an all-cash deal, emphasizing growth in pharmaceutical technologies as they expand their portfolio.
third-news.com
June 23, 2025 at 1:47 PM
Milwaukee Capital Partners Completes All-Cash Acquisition of MPP Group#United_States#Milwaukee#Concordia_University#Milwaukee_Capital#MPP_Group